Viewing Study NCT03161093


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-03-02 @ 4:12 AM
Study NCT ID: NCT03161093
Status: COMPLETED
Last Update Posted: 2022-11-14
First Post: 2017-05-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip
Sponsor: Regeneron Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-08-17
Start Date Type: ACTUAL
Primary Completion Date: 2019-09-09
Primary Completion Date Type: ACTUAL
Completion Date: 2021-08-27
Completion Date Type: ACTUAL
First Submit Date: 2017-05-18
First Submit QC Date: None
Study First Post Date: 2017-05-19
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-08-25
Results First Submit QC Date: None
Results First Post Date: 2022-11-14
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2022-11-14
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2022-10-18
Last Update Post Date: 2022-11-14
Last Update Post Date Type: ACTUAL